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Abstract
Background: Hypophosphatasia is a rare inherited disease derived from mutations in tissue non-specific alkaline
phosphatase genes, with typical oral symptoms including short root anomaly and dysplasia of dentin or cementum.
Case presentation: Two young female patients presented with short root anomaly with a history of premature loss
of deciduous and/or permanent teeth. The laboratory and imaging investigations were performed. One case was
diagnosed as odontohypophosphatasia concurrent with hyperthyroidism, the other was odontohypophosphatasia
concurrent with multiple radicular cysts.
Conclusion: This report presents two cases of odontohypophosphatasia, a rare disease which is difficult to be
diagnosed, and highlights that the history of premature loss of deciduous and/or permanent teeth, oral
manifestation and laboratory tests are crucial for clinical diagnosis.
Keywords: Alkaline phosphatase, Cone-beam computed tomography, Dysplasia, Hyperthyroidism, Radicular cyst,
Short root anomaly
Background
Hypophosphatasia (HPP) is a rare inherited disease
mainly characterized by bone and tooth dysplasia result-
ing from low serum level or activity of alkaline phos-
phatase (ALP), especially tissue non-specific alkaline
phosphatase (TNSALP). HPP can occur from perinatal
to adult stages and is categorized into 6 forms with dif-
ferent clinical manifestations, including perinatal (lethal),
prenatal (benign), infantile, childhood, adult, and odon-
tohypophosphatasia forms [1]. Research has indicated
that the incidence of severe forms is about 1/100,000,
and the total incidence of the disease is generally under-
estimated for the reason that mild forms are always ig-
nored [2]. The typical oral symptoms include short root
anomaly and dysplasia of dentin or cementum. Some pa-
tients may only present with a history of premature loss
of deciduous and/or permanent teeth. Therefore a thor-
ough understanding of the disease is of great importance
for dentists. In addition to clinical manifestations, bio-
chemical tests and/or the genetic analyses are also
crucial to the diagnosis of the disease. We presented two
cases of odontohypophosphatasia form of HPP to illus-
trate the characteristics of this inherited disease. Cone-
beam computed tomography (CBCT) was applied for
better evaluation of short root anomaly.
Case presentation
This study was approved by the Institutional Review
Board of Guanghua School of Stomatology, Sun Yat-sen
University (Reference No. ERC-[2014]-18). Informed
consent was obtained from both patients. Dental, med-
ical and family history of two patients with short root
anomaly were recorded in detail. Clinical examination
and diagnostic radiography were performed at Hospital
of Stomatology, Sun Yat-sen University, Guangzhou,
China. CBCT was applied to measure the length of the
crown and the root of teeth [3]. The laboratory examina-
tions including urinalysis, complete blood count, serum
ALP level, serum calcium level, serum calcitonin (CT)
level, serum parathyroid hormone (PTH) level, serum
free triiodothyronine (FT3) level, serum free thyroxine
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(FT4) level and serum thyroid-stimulating hormone
(TSH) level were conducted.
Case one
A 27-year-old female Chinese patient presented with
looseness of her maxillary incisors (teeth #11 and #12)
was treated with an arch bar from tooth #14 to tooth
#22 for 5 months in outside institution. She then suf-
fered from upper incisors pain and was referred to us.
The patient was 160 cm height and 46.5 kg weight,
with a Body Mass Index (BMI) of 18.2 (normal range
18.5–23.9). She also had mild symptoms of heat intoler-
ance, anxiety, polyphrasia, tremor, palpitate, chest tight-
ness, anhelation, and muscle aches. The patient had a
history of premature loss of some deciduous teeth in
childhood. The family history was unremarkable. Physical
examination revealed mild goiter and exophthalmos.
Intraoral examination found pale spots on the crowns due
to mild enamel hypoplasia (Fig. 1a). No tender to percus-
sion, and no tooth mobility after removal of the arch bar.
Periapical and panoramic radiographs showed that the
roots of all teeth were short (Fig. 1b-e).CBCT scan
(Fig. 1f, g) proved that the lengths of all the roots (ex-
cept for four 3rd molars) were shorter than normal,
whereas the crowns lengths were broadly within the nor-
mal range (Table 1). Chest X-ray and skeletal radio-
graphs of upper and lower limbs didn’t show any
significant changes. The laboratory analyses of urinalysis,
complete blood count, serum calcium level, serum CT
level, and PTH level were normal. Serum ALP level was
59.0 U/L (normal range 45.0–125.0 U/L). Unexpectedly,
serum TSH level was lower than 0.011 uIU/mL (normal
range 0.270–4.200 uIU/mL), serum FT3 7.52 pmol/L
(normal range 3.10–6.80 pmol/L), and serum FT4 18.33
pmol/L (normal range 12.00–22.00 pmol/L).
With consultation by an endocrinologist, the patient
was diagnosed as HPP (odontohypophosphatasia form)
and hyperthyroidism [4, 5]. Since serum ALP level in
patients with hyperthyroidism would be higher than
normal [4, 6, 7], we suspected that this might compen-
sate the reduction of ALP level caused by HPP and thus
led to the false-negative result of serum ALP level in this
case.
Case two
A 24-year-old female Chinese patient presented with re-
peated episodes of swelling and pain of her chin for 2
years. The patient had a history of premature loss of
some deciduous teeth before 6-year-old and accidental
leg fracture at 10-year-old. Family history revealed that
her mother lost several teeth at 40-year-old. The patient
was 160 cm height and 39 kg weight, with a BMI of 15.23.
Intraoral examination (Fig. 2a-c) and CBCT showed
enamel hypoplasia in most of her residual teeth. Teeth
#14 and # 31 were missing. No fistula or pus was noted.
The panoramic film (Fig. 2d) revealed that all the roots
were short, and multiple well defined radiolucencies
were shown at the apices of teeth #25, #26, #32–35, and
#41–46. Furthermore, alveolar bone height reduction
was observed as well. CBCT proved that most of the
root lengths were shorter than normal (Table 2). Skeletal
radiography didn’t show any obvious changes. The la-
boratory examination results were unremarkable except
that the serum ALP level was 35.0 U/L (normal range
45.0–125.0 U/L).
The patient was diagnosed as HPP (odontohypopho-
sphatasia form) and multiple radicular cysts [5]. Root
canal therapy of teeth #25, #26, #33–35, and #41–44 was
performed before enucleation of the radicular cysts. In
addition, teeth #32, #45, and #46 were extracted. Patho-
logical report confirmed the diagnosis of radicular cysts
(Fig. 2e-g).
Discussion
In the present study, two cases of odontohypophospha-
tasia form of HPP were reported, one concurrent with
hyperthyroidism, and the other concurrent with multiple
radicular cysts. To our knowledge, this is the first report
that multiple radicular cysts and hyperthyroidism pre-
sented with odontohypophosphatasia form of HPP.
HPP patients possess mutations in the TNSALP gene,
resulting in low serum level or activity of ALP, which
can cause mineralization disorders and finally progress
to bone or tooth dysplasia [5]. More than 270 distinct
mutations and 15 polymorphisms have been recorded so
far [8]. Different forms of HPP have quite different clin-
ical manifestations despite the similar pathogenesis. Peri-
natal (lethal) form is an autosomal recessive disease and
mostly the fetus would die of dyspnoea or the dysfunc-
tion of bone formation [9]. Prenatal (benign) form is an
autosomal recessive or autosomal dominant disease pre-
senting with obvious long bone deformity in infantile
period without serious bone mineralization defects.
Infantile form is an autosomal recessive disease and also
generally considered lethal since the infants would suffer
from dyspnoea caused by respiratory complication.
Childhood form is an autosomal recessive or autosomal
dominant disease presenting with several oral and sys-
temic symptoms in children [10]. Adult form is an auto-
somal recessive or autosomal dominant disease which
presents with recurrent stress fractures, thigh pain,
osteoarthropathy, and premature loss of deciduous and/
or permanent teeth [11]. Odontohypophosphatasia form
is an autosomal recessive or autosomal dominant dis-
ease, which seems to present only in a dental phenotype.
The diagnosis of this form remains controversial. It is
characterized by premature loss of deciduous and/or
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Fig. 1 Clinical and imaging manifestation of Case 1. a Frontal intraoral view shows the teeth crowns appear normal except for several spots due
to mild enamel hypoplasia. b-d Periapical radiographs show the short root anomaly of the maxillary incisors. e Panoramic film. f-g Teeth lengths
were measured by CBCT
Wang et al. BMC Oral Health  (2016) 16:70 Page 3 of 8
permanent teeth (commonly the incisors), but not asso-
ciated with deformities of the bone. The affected teeth
may present dentin or cemental hypoplasia, enlarged
root canals and pulp chambers. Biochemical findings are
generally not considered as gold standard because the
serum ALP level could be only slightly lower than nor-
mal, or even within the normal range [8, 12, 13]. There-
fore any patient with a history of unexplainable
premature loss of deciduous and/or permanent teeth
should be suspected [13].
Although conspicuously different from each other in
clinical manifestations, the oral symptoms are quite
similar among varied forms. Premature loss of deciduous
and/or permanent teeth is significant for diagnosis,
which presented in both patients in our study. Alveolar
bone height reduction, short root anomaly, and expand-
ing root or pulp chamber are common oral manifesta-
tions [14–17]. Additionally, enamel hypoplasia, dentin
dysplasia and cemental hypoplasia are also frequently
observed [18]. Periodontal diseases such as gingivitis and
Table 1 Crown length, root length and tooth length of patient one
Crown length Root length Tooth length
CL (mm) n CL (mm) n CLR (mm) RL (mm) n RL (mm) n RLR (mm) TL (mm) n TL (mm) n TLR (mm)
#11 10.9 11.2 8.6–14.7 3.5 a 13.0 6.3–20.3 14.4 a 23.6 16.5–32.6
#21 10.6 4.0 a 14.6 a
#12 8.2 9.8 7.4–11.9 7.0 a 13.4 9.6–19.4 15.2 a 22.5 17.7–28.9
#22 8.5 5.7 a 14.2 a
#13 8.6 10.6 8.2–13.6 8.2 a 16.5 10.8–28.5 16.8 a 26.4 20.0–38.4
#23 8.2 8.2 a 16.4 a
#14 6.1a 8.6 7.1–11.1 7.3 a 13.4 8.3–19.0 13.4 a 21.5 15.5–28.9
#24 5.6a 6.6 a 12.2 a
#15 4.8a 7.7 5.2–10.5 7.8 a 14.0 8.0–20.6 12.6 a 21.2 15.2–28.4
#25 5.7 7.7 a 13.4 a
#16 6.1a 7.5 6.3–9.6 7.7 a 12.9 9.3–17.3 13.8 a 20.1 17.0–27.4
#26 5.3a 8.2 a 13.5 a
#17 5.8a 7.6 6.1–9.4 8.1 a 12.9 9.3–17.8 13.9 a 20.0 16.0–26.2
#27 5.4a 8.0 a 13.4 a
#18 6.2 7.2 5.7–9.0 7.1 10.7 7.1–15.3 13.2 a 17.5 14.0–22.5
#28 6.0 7.5 13.5 a
#41 6.6 8.8 6.3–11.6 7.1 a 12.6 7.7–17.9 13.7 a 20.8 16.9–26.7
#31 6.4 6.8 a 13.2 a
#42 7.8 9.4 7.3–12.6 6.9 a 13.5 9.4–18.1 14.7 a 22.1 18.5–26.6
#32 7.3 7.9 a 15.2 a
#43 8.5 11.0 6.8–16.4 9.3 a 15.9 9.5–22.5 17.8 25.9 16.1–34.5
#33 8.4 9.3 a 17.7
#44 7.6 8.2 5.9–10.9 8.8 a 14.7 9.7–20.2 16.4 a 22.4 17.0–28.5
#34 8.1 8.1 a 16.2 a
#45 6.7 8.8 6.7–10.2 8.4 a 14.4 9.2–21.2 15.1 a 22.1 16.8–28.1
#35 7.1 7.2 a 14.3 a
#46 6.3 7.7 6.1–9.6 8.9 a 13.5 9.3–18.9 15.2 a 20.9 17.0–27.7
#36 6.6 8.7 a 15.3 a
#47 6.9 7.7 6.1–9.8 7.2 a 13.5 8.9–18.8 14.1 a 20.6 15.0–25.5
#37 6.5 8.2 a 14.7 a
#48 6.5 7.5 6.1–9.2 6.8 11.2 6.3–14.3 13.3 a 18.2 14.8–22.0
#38 6.6 6.7 13.3 a
CL crown length, n CL normal average crown length, n CLR normal range of crown length, RL root length, n RL normal average root length, n RLR normal range of
root length, TL tooth length, n TL normal average tooth length, n TLR, normal range of tooth length
a indicates that the length is shorter than the lower limit of the normal range. All the normal data are obtained from Woelfel’s Dental Anatomy [31]
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Fig. 2 Clinical and imaging manifestation of Case 2. a-c Intraoral view shows the dysplasia. D. Panoramic film shows the short root anomaly.
e-g Histological analysis of the radicular cysts. e cyst wall of the radicular cyst, with Rushton body (black arrow in f) and inflammatory cell
infiltration (white arrow in g)
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periodontitis are rare in HPP [19]. Our present study
firstly reported that multiple radicular cysts occurred in
patient with odontohypophosphatasia form of HPP. It is
believed that cemental hypoplasia, especially acellular
cemental hypoplasia, plays a major part in the oral mani-
festation [20]. Inorganic pyrophosphate (PPi) acts as an
indispensable regulator for root acellular cementum de-
velopment, and is a key determinant that defines the
hard-soft interface between the periodontal ligament
and cementum. Acellular extrinsic fiber cementum, a tis-
sue vital to tooth attachment and function, would be
affected by high PPi level resulting from low ALP activ-
ity. That is to say, low serum ALP level or activity could
lead to severe dysplasia or even absence of acellular ce-
mentum. Acellular cemental hypoplasia could influence
the development of root and periodontal ligament at-
tachment which would eventually result in premature
loss of deciduous and/or permanent teeth [20].
A definitive diagnosis of HPP is usually not so distinct
to be made. Although skeletal radiographs are easy to
obtain, patients with odontohypophosphatasia form of
HPP may not present any bone deformities such as
Table 2 Crown length, root length and tooth length of patient two
Crown length Root length Tooth length
CL (mm) n CL (mm) n CLR (mm) RL (mm) n RL (mm) n RLR (mm) TL (mm) n TL (mm) n TLR (mm)
#11 6.3* 11.2 8.6–14.7 9.9 13.0 6.3–20.3 16.2* 23.6 16.5–32.6
#21 6.5* 9.8 16.3*
#12 6.1* 9.8 7.4–11.9 8.9* 13.4 9.6–19.4 15.0* 22.5 17.7–28.9
#22 5.9* 9.3* 15.2*
#13 6.1* 10.6 8.2–13.6 9.7* 16.5 10.8–28.5 15.8* 26.4 20.0–38.4
#23 6.2* 9.8* 16.0*
#14 0.0* 8.6 7.1–11.1 0.0 13.4 8.3–19.0 0.0 21.5 15.5–28.9
#24 5.8* 9.0 14.8*
#15 5.9 7.7 5.2–10.5 9.1 14.0 8.0–20.6 15.0* 21.2 15.2–28.4
#25 5.7 9.1 14.8*
#16 6.1* 7.5 6.3–9.6 8.5* 12.9 9.3–17.3 14.6* 20.1 17.0–27.4
#26 5.8* 8.5* 14.3*
#17 5.8* 7.6 6.1–9.4 8.9* 12.9 9.3–17.8 14.7* 20.0 16.0–26.2
#27 5.4* 8.8* 14.2*
#18 0.0 7.2 5.7–9.0 0.0 10.7 7.1–15.3 0.0 17.5 14.0–22.5
#28 0.0 0.0 0.0
#41 3.4* 8.8 6.3–11.6 9.4 12.6 7.7–17.9 12.8* 20.8 16.9–26.7
#31 0.0 0.0 0.0
#42 4.4* 9.4 7.3–12.6 8.1* 13.5 9.4–18.1 12.5* 22.1 18.5–26.6
#32 3.1* 8.0* 11.1*
#43 5.4* 11.0 6.8–16.4 10.1 15.9 9.5–22.5 15.5* 25.9 16.1–34.5
#33 5.2* 9.5 14.7*
#44 5.0* 8.2 5.9–10.9 9.4* 14.7 9.7–20.2 14.4* 22.4 17.0–28.5
#34 4.9* 9.6* 14.5*
#45 5.2* 8.8 6.7–10.2 10.0 14.4 9.2–21.2 15.2* 22.1 16.8–28.1
#35 5.1* 9.8 14.9*
#46 1.4* 7.7 6.1–9.6 8.7* 13.5 9.3–18.9 10.1* 20.9 17.0–27.7
#36 5.8* 8.2* 14.0*
#47 5.9* 7.7 6.1–9.8 8.5* 13.5 8.9–18.8 14.4* 20.6 15.0–25.5
#37 5.8* 8.1* 13.9*
#48 0.0 7.5 6.1–9.2 0.0 11.2 6.3–14.3 0.0 18.2 14.8–22.0
#38 0.0 0.0 0.0
Length 0.0 means the tooth was already lost
*indicates that the length is shorter than the lower limit of the normal range. All the normal data are obtained from Woelfel’s Dental Anatomy [31]
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craniomalacia or rachitic changes [5]. With the use of
CBCT, minor structural changes of teeth would be iden-
tified. Serum ALP level or activity, which could be de-
tected easily, indicates the severity of HPP, but can
sometimes show false-negative [4, 21, 22]. Diseases such
as hepatic carcinoma, hyperthyroidism and multiple ra-
dicular cysts may present high serum ALP level and
therefore interfere the result [4, 21, 22]. The acellular ce-
mentum is more sensitive than bone tissue to serum
ALP level change, since PPi plays an important role in
acellular cementum development [20]. Genetic analysis
can detect the mutation genes for the diagnosis of this
inherited disease [23]. In addition, the differential diag-
nosis of X-linked hypophosphatemia, caused by the
mutation in phosphate-regulating gene with homologies
to endopeptidases on the X chromosome (PHEX) gene
sequence, should be taken into consideration. With
reduced PHEX enzymatic activity, osteopontin could
accumulate in the bone and cause osteomalacia [24]. In
our cases, symptoms of hypophosphatemia and osteo-
malacia were not observed.
It is generally consented that, the earlier the onset of
HPP is, the more severe the disease gets, and the worse
the prognosis will be. Although some symptoms could
relieve spontaneously in mild form, the management is
still under investigation [14]. High phosphate prepara-
tions like neutral sodium phosphate or biphosphonates
could elevate serum phosphate level and increase the
urinary excretion of PPi [25]. Surgical treatment could
alleviate bone deformities [26]. Bone marrow transplant-
ation can mitigate the respiratory complication and bone
deformities in perinatal form patients [27]. Enzyme re-
placement therapy, high-dose subcutaneous injection of
a mineral-targeting human TNSALP (sALP-FcD10),
could prevent the symptoms of infantile form HPP in
TNSALP-null mice [28]. What’s more, the enzyme re-
placement therapy asfotase alfa (Strensiq™; Alexion Phar-
maceuticals Inc, New Haven, CT, USA), a recombinant
human TNSALP, showed remarkable curative effect such
as improvements in skeletal manifestation, pulmonary
function, and growth in perinatal or infantile form HPP
patients [29]. Recently asfotase alfa was approved in the
USA, Canada, and Europe for the treatment of peri-
natal/infantile- and juvenile-onset HPP, and in Japan for
the treatment of HPP [18]. Another exciting field is the
potential application of genetic therapy. Injection of the
viral vector with TNSALP gene to mice could maintain
the serum TNSALP at a high level and alleviate the
symptoms, which also provides a promising approach in
the management of HPP in the future [30]. In the
present study, the first patient achieved relief of symp-
toms after removal of arch bar and kept asymptomatic
during 24 months follow-up. The second case was
treated with enucleation of radicular cysts after the root
canal treatment of the affected teeth. The patient was
followed up for 21 months without any symptoms.
Conclusions
Odontohypophosphatasia form of hypophosphatasia is a
rare disease which is difficult to be diagnosed because of
lack of systemic symptoms. This report presents two cases
of odontohypophosphatasia concurrent with hyperthy-
roidism or multiple radicular cysts, and highlights that the
history of premature loss of deciduous and/or permanent
teeth, oral manifestation and lab results provide critical in-
formation for clinical diagnosis.
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